Patents by Inventor Colin Meyer

Colin Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR ANALOGS THEREOF
    Publication number: 20230255982
    Abstract: The present invention provides methods of treating patients infected with a coronavirus. In particular, provided are methods of treating or preventing COVID-19, or symptoms or complications thereof, in patients in need thereof using bardoxolone methyl or analogs thereof, and/or preventing the onset of COVID-19 in patients infected with SARS-COV-2.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 17, 2023
    Applicant: REATA PHARMACEUTICALS HOLDINGS, LLC
    Inventors: Deborah FERGUSON, W. Christian WIGLEY, Colin MEYER, J. Warren HUFF, Robert M. KRAL, Jr.
  • COMBINATION THERAPY WITH SYNTHETIC TRITERPENOIDS AND GEMCITABINE
    Publication number: 20090048205
    Abstract: The present invention concerns methods for treating cancer, such as pancreatic cancer, using combination therapies, including the combination of a synthetic triterpenoid, e.g., CDDO-Me, and gemcitabine.
    Type: Application
    Filed: August 15, 2008
    Publication date: February 19, 2009
    Inventors: Colin Meyer, Michael Andreeff, Marina Konopleva, Robert M. Kral, JR.